Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin N Hascup

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Medicine|April 2, 2025
Editorial: Delirium in older personsPaolo Mazzola, Kevin N Hascup
Journal of Alzheimer'S Disease : JAD|November 7, 2014
Altered neurotransmission prior to cognitive decline in AβPP/PS1 mice, a model of Alzheimer's diseaseKevin N Hascup, Erin R Hascup
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
Toward refining Alzheimer's disease into overlapping subgroupsErin R Hascup, Kevin N Hascup
Geroscience|May 27, 2020
Does SARS-CoV-2 infection cause chronic neurological complications?Erin R Hascup, Kevin N Hascup
Comparative Medicine|October 9, 2014
Electrochemical techniques for subsecond neurotransmitter detection in live rodentsKevin N Hascup, Erin R Hascup
Journal of Alzheimer'S Disease : JAD|May 11, 2016
Soluble Amyloid-β42 Stimulates Glutamate Release through Activation of the α7 Nicotinic Acetylcholine ReceptorKevin N Hascup, Erin R Hascup
Journal of Alzheimer'S Disease : JAD|June 30, 2020
Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular DysfunctionErnesto Solis, Kevin N Hascup, Erin R Hascup
Frontiers in Aging|July 13, 2022
Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer's DiseaseMaKayla F Cox, Erin R Hascup, Andrzej Bartke, et al.
ASN Neuro|June 20, 2019
Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer's Disease ProgressionCaleigh A Findley, Andrzej Bartke, Kevin N Hascup, et al.
Frontiers in Cellular Neuroscience|July 3, 2024
Microglial Piezo1 mechanosensitive channel as a therapeutic target in Alzheimer's diseaseErol D Ikiz, Erin R Hascup, Chilman Bae, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Medicine|April 2, 2025
Editorial: Delirium in older personsPaolo Mazzola, Kevin N Hascup
Journal of Alzheimer'S Disease : JAD|November 7, 2014
Altered neurotransmission prior to cognitive decline in AβPP/PS1 mice, a model of Alzheimer's diseaseKevin N Hascup, Erin R Hascup
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
Toward refining Alzheimer's disease into overlapping subgroupsErin R Hascup, Kevin N Hascup
Geroscience|May 27, 2020
Does SARS-CoV-2 infection cause chronic neurological complications?Erin R Hascup, Kevin N Hascup
Comparative Medicine|October 9, 2014
Electrochemical techniques for subsecond neurotransmitter detection in live rodentsKevin N Hascup, Erin R Hascup
Journal of Alzheimer'S Disease : JAD|May 11, 2016
Soluble Amyloid-β42 Stimulates Glutamate Release through Activation of the α7 Nicotinic Acetylcholine ReceptorKevin N Hascup, Erin R Hascup
Journal of Alzheimer'S Disease : JAD|June 30, 2020
Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular DysfunctionErnesto Solis, Kevin N Hascup, Erin R Hascup
Frontiers in Aging|July 13, 2022
Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer's DiseaseMaKayla F Cox, Erin R Hascup, Andrzej Bartke, et al.
ASN Neuro|June 20, 2019
Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer's Disease ProgressionCaleigh A Findley, Andrzej Bartke, Kevin N Hascup, et al.
Frontiers in Cellular Neuroscience|July 3, 2024
Microglial Piezo1 mechanosensitive channel as a therapeutic target in Alzheimer's diseaseErol D Ikiz, Erin R Hascup, Chilman Bae, et al.
Pageof 5